Cargando…
Is there justification for universal leukoreduction?
Autores principales: | Mendrone, Alfredo, Fabron, Antonio, Langhi, Dante, Covas, Dimas Tadeu, Dinardo, Carla Luana, Ubiali, Eugênia Amorim, Marques, José Francisco Comenalli, Bordin, José Orlando, Rugani, Marilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207925/ https://www.ncbi.nlm.nih.gov/pubmed/25031158 http://dx.doi.org/10.1016/j.bjhh.2014.06.004 |
Ejemplares similares
-
Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19
por: De Santis, Gil Cunha, et al.
Publicado: (2021) -
Guidelines on transfusion of red blood cells: Prognosis of patients who decline blood transfusions
por: Langhi, Dante Mário, et al.
Publicado: (2018) -
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VI: Accreditation process
por: De Santis, Gil Cunha, et al.
Publicado: (2021) -
Guidelines on Beta-thalassemia major – regular blood transfusion therapy: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: project guidelines: Associação Médica Brasileira – 2016
por: Langhi, Dante, et al.
Publicado: (2016) -
Serological and Molecular Study of the Duffy Blood Group among Malarial Endemic Region Residents in Brazil
por: Langhi, Dante, et al.
Publicado: (2022)